Endocrine-disrupting chemicals: associated disorders and mechanisms of action.

De Coster S, van Larebeke N. · 2012

Read Endocrine-disrupting chemicals: associated disorders and mechanisms of action. by De Coster S, van Larebeke N. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3443608.txt.

Introduction

De Coster and van Larebeke catalogued in 2012 the health disorders tied to endocrine-disrupting chemicals and the many ways those chemicals act. Such substances, from bisphenol A and phthalates to flame retardants, pesticides, and even some metals, have spread everywhere. Rates of related problems, including several cancers, diabetes, obesity, and infertility, have climbed over the same decades.

The review lists the observations linking disruptors to those conditions, with the caveat that rising diagnosis explains part of the trends. Mechanisms run far beyond the classic hormone receptors: membrane receptors, enzyme cross-talk, altered hormone metabolism, broken feedback loops, and changes to DNA tags all feature. Effects can even depend on which chemical flips a given switch. The breadth itself is the warning.

Catalog record

CREATORDe Coster S, van Larebeke N.
YEAR2012
COLLECTIONPAPERS
FORMATTXT
FILE SIZE193 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3443608

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Endocrine-Disrupting Chemicals: Associated Disorders and Mechanisms of Action By Sam De Coster, Nicolas van Larebeke Published in: Journal of Environmental and Public Health DOI: 10.1155/2012/713696 ABSTRACT Abstract The incidence and/or prevalence of health problems associated with endocrine-disruption have increased. Many chemicals have endocrine-disrupting properties, including bisphenol A, some organochlorines, polybrominated flame retardants, perfluorinated substances, alkylphenols, phthalates, pesticides, polycyclic aromatic hydrocarbons, alkylphenols, solvents, and some household products including some cleaning products, air fresheners, hair dyes, cosmetics, and sunscreens. Even some metals were shown to have endocrine-disrupting properties. Many observations suggesting that endocrine disruptors do contribute to cancer, diabetes, obesity, the metabolic syndrome, and infertility are listed in this paper. An overview is presented of mechanisms contributing to endocrine disruption. Endocrine disruptors can act through classical nuclear receptors, but also through estrogen-related receptors, membrane-bound estrogen-receptors, and interaction with targets in the cytosol resulting in activation of the Src/Ras/Erk pathway or modulation of nitric oxide. In addition, changes in metabolism of endogenous hormones, cross-talk between genomic and nongenomic pathways, cross talk with estrogen receptors after binding on other receptors, interference with feedback regulation and neuroendocrine cells, changes in DNA methylation or histone modifications, and genomic instability by interference with the spindle figure can play a role. Also it was found that effects of receptor activation can differ in function of the ligand. 1. INTRODUCTION The objectives of the present paper include to give an overview of the wide spectrum of substances having endocrine-disrupting properties; to list a series of observations suggesting that endocrine disruptors contribute to human health problems, however, without attempting to bring an all-inclusive review for each individual substance accompanied by a final conclusion; to give an overview of the many mechanisms on which endocrine disruption rests. 2. INCIDENCE AND PREVALENCE OF HEALTH PROBLEMS ASSOCIATED WITH ENDOCRINE DISRUPTION HAVE INCREASED Epidemiological data show increases in incidence and prevalence of diseases associated with endocrine-disrupting chemicals, such as breast, prostate, and testis cancer, diabetes, obesity, and decreased fertility over the last 50 years. A short overview of supporting data is presented below. These increases might partly reflect an increase in the likelihood of diagnosis and certainly do not constitute proof of the impact of endocrine-disrupting chemicals. Time trends and ecological studies are not well suited to study a possible association between exposure to endocrine disrupting chemicals and risk of disease, as assessment of exposure is extremely difficult. The data on time trends are, however, consistent with such an impact, as are data on the incidence or prevalence of some diseases in migrants and on differences in function of geographical area. Huge geographical differences in cancer incidence are well documented in the report “Cancer incidence in five continents, volume IX” of the International Agency for Research on Cancer [1], often showing higher risks of hormone-related cancers in more industrialized countries. In France, cancer mortality among migrants is positively associated with the Human Development Index of the country-of-birth [2]. In migrants to California, time since immigration is associated with convergence of the odds for mortality from cancer and from some other diseases to that of the native population [3]. In the Netherlands (for cancer mortality) [4], in British Columbia (for cancer incidence) [5], in the San Francisco Bay area (for risk of breast cancer) [6], and in Hawai (for cancer incidence among Japanese) [7], convergence towards the rates of the native population was reported. A systematic review and meta-analysis revealed that prevalence of obesity is higher among migrant Asian Indians than among Indians living in India [8]. In India, migration from rural to urban area's is associated with an increase in the prevalence of diabetes and obesity [9]. 2.1. Cancer In Great Britain, from 1978 to 2007, the overall age-standardized incidence rate of cancer has increased by 25%, an increase of 14% in men and a 32% increase in women [10] (see Figure 1). [Figure: Age standardized (European) incidence rates for all cancers excluding nonmelanoma skin cancer, Great Britain 1975–2008. Figure taken from the web-site of the UK Cancer in Research organisation, accessed on 18/2/2011 [10].] According to Great Britain statistics, breast and prostate cancer incidence have a higher relative increase in incidence. Prostate cancer incidence has almost tripled from 33 per 100,000 in 1975 to 97 per 100,000 in 2007, while the incidence of breast cancer for women increased by 57%, from 77 per 100,000 in 1978 to 120 per 100,000 in 2007 (see Figures 2 and 3) [10]. These trends are being observed worldwide [11, 12]. Also the incidence of testis cancer has increased worldwide [13]. The increase in cancer incidence can partly be explained by the introduction of screening, which will result in a transient increase in incidence and a stage shift to earlier stages, microinvasive, and in situ cancers in the steady state situation [14]. It is, however very unlikely that early screening explains the entire rise in cancer incidence, because of the progressive nature of the cancer process, which leads almost always to clinically evident disease. Also, in the United States Incidence rates for all childhood cancers combined increased 0.6% per year from 1975 to 2002 [15], while cancer is a disease which, since many decades, is diagnosed more easily in children compared to elderly because of the particular impact of the disease on children. [Figure: Age standardized (European) incidence and mortality rates for breast cancer in females in Great Britain 1975–2008. Figure taken from the web-site of the UK Cancer Research organisation, accessed on 18/2/2011 [10].] [Figure: Age standardized (European) incidence and mortality rates for prostate cancer in males in Great Britain 1975–2008. Figure taken from the web-site of the UK Cancer Research organisation, accessed on 18/2/2011 [10].] 2.2. Diabetes The United States Centre for Disease Control and Prevention (CDC) reports percentages of diabetes incidence of 0.93% in 1958 against 6.29% in 2008, which is a more than 6-fold increase, as is shown in Figure 4 [16]. [Figure: Number and percentage of US population with diagnosed diabetes 1958–2008, according to the CDC. Figure taken from the web-site of the Centers for Disease Control and Prevention, accessed on 18/2/2011 [16].] 2.3. Obesity The CDC reports an increase of obesity prevalence (BMI ≥ 30) in US adults (20–74 years) from 13.4% in 1960–1962 to 35.1% in 2005-2006. Extreme obesity (BMI ≥ 40) has increased from 0.9% to 6.2% in the same period. Figure 5 shows obesity trends among US residents over the last 50 years [17]. [Figure: rends in overweight, obesity and extreme obesity over the last 50 years in the U.S, according to the CDC. Figure taken from the web-site of the Centers for Disease Control and Prevention, accessed on 18/2/2011 [17].] 2.4. Metabolic Syndrome In the United States, an increase in the prevalence of metabolic syndrome has been reported from 4.2% to 6.4% in adolescents, and from 23.1% to 26.7% in adults [18, 19]. 2.5. Decreased Fertility In men fertility has been decreasing in the last decades, at least in some countries. Observations by Comhaire and colleagues [75] on candidate sperm donors show that this has been the case in Flanders (see Figure 6). Similar observations were made in Denmark [76], in France [77], and in the United Kingdom [78]. From a thorough analysis of 101 studies published 1934–1996

Read the complete text